Back
Galectin Therapeutics Vs. Enanta Pharmaceuticals Industry Stock Comparison
Sell
47
GALT
Galectin Therapeutics
Last Price:
3.15
Seasonality Move:
-7.91%
Sell
34
ENTA
Enanta Pharmaceuticals
Last Price:
13.05
Seasonality Move:
-0.7%
Sell
47
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy, Sell or Hold?
- The current Galectin Therapeutics [GALT] share price is $3.06. The Score for GALT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- GALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy, Sell or Hold?
- The current Enanta Pharmaceuticals [ENTA] share price is $13.34. The Score for ENTA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- ENTA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GALT Stock Price Chart
What is Galectin Therapeutics's stock price today?
-
The Galectin Therapeutics share price today is $3.06
The current trend is relatively stagnant and GALT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ENTA Stock Price Chart
What is Enanta Pharmaceuticals's stock price today?
-
The Enanta Pharmaceuticals share price today is $13.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing selling pressure, which indicates risk of future bearish movement.
GALT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 46.21 | Sell |
Chaikin Money Flow: | 88261 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.1 - 3.7) | Sell |
Bollinger Bands (100): | (1.61 - 3.11) | Buy |
ENTA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.43 | Sell |
Relative Strength Index (14 RSI): | 46.05 | Sell |
Chaikin Money Flow: | -59137 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.57 - 15.01) | Sell |
Bollinger Bands (100): | (11.5 - 15.32) | Sell |
GALT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.16 | Sell |
20-day SMA: | 3.3 | Sell |
50-day SMA: | 2.96 | Buy |
200-day SMA: | 2.1 | Buy |
8-day EMA: | 3.13 | Sell |
20-day EMA: | 3.22 | Sell |
50-day EMA: | 2.98 | Buy |
200-day EMA: | 2.27 | Buy |
ENTA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.19 | Buy |
20-day SMA: | 13.3 | Buy |
50-day SMA: | 14.62 | Sell |
200-day SMA: | 12.5 | Buy |
8-day EMA: | 13.24 | Buy |
20-day EMA: | 13.62 | Sell |
50-day EMA: | 13.94 | Sell |
200-day EMA: | 16.1 | Sell |
Galectin Therapeutics Earnings Growth & GALT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.36 per share, and an increase next year of $0.46 per share.
Galectin Therapeutics Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Enanta Pharmaceuticals Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |